IP Library Granted Patent US 9,408,827
Granted Patent B2
US 9,408,827 · App. 13/901,963 · Granted Aug 9, 2016

Sheet for cutaneous application containing vitamin E or an ester thereof

Inventor: Giorgio Panin (Rovigo, IT)
Assignee: BIO.LO.GA S.R.L.
A61K31/355A61L15/26A61L15/44A61L2300/428
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,408,827
App. No.
13/901,963
Granted
Aug 9, 2016
Kind
B2
Abstract

Sheet for cutaneous application comprising a support layer made of loosely woven fabric embedded in a layer of silicone elastomer incorporating vitamin E or an ester thereof, wherein the layer of silicone elastomer has a thickness less than or equal to 2.0 mm and the silicone elastomer contains an elasticity modifier consisting of a triglyceride of saturated C 8 -C 18 fatty acids.

Claims (28)

1. A sheet for cutaneous application comprising a support layer made of loosely woven fabric embedded in a solid layer of cross-linked silicone elastomer having dispersed therein vitamin E or an ester thereof,

wherein said layer of silicone elastomer has a thickness less than or equal to 2.0 mm and said solid layer of silicone elastomer having further dispersed therein an elasticity modifier consisting of a triglyceride of saturated C 8 -C 18 fatty acids, and

wherein said cross-linked silicone elastomer in said solid layer is present in an amount that is greater than said vitamin E or an ester thereof and said triglyceride in said solid layer, and said triglyceride is present in an amount less than said vitamin E or an ester thereof.

2. The sheet according to claim 1 , wherein said loosely woven fabric is gauze.

3. The sheet according to claim 2 , wherein said gauze is a cotton gauze.

4. The sheet according to claim 1 , wherein said silicone elastomer incorporates an ester of vitamin E with a carboxylic acid of formula R—COOH, wherein R is an alkyl radical having 1 to 19 carbon atoms, or an alkenyl or alkynyl radical having 2 to 19 carbon atoms.

5. The sheet according to claim 4 , wherein said ester of vitamin E is vitamin E acetate, n-propionate or linoleate.

6. The sheet according to claim 5 , wherein said ester of vitamin E is alpha-tocopheryl acetate.

7. The sheet according to claim 1 , wherein said vitamin E or ester thereof is dispersed in said layer of silicone elastomer in an amount comprised between 2% and 40%.

8. The sheet according to claim 1 , wherein said vitamin E or ester thereof is dispersed in said layer of silicone elastomer in an amount comprised between 5% and 30%, by weight of the weight of the silicone elastomer.

9. The sheet according to claim 1 , wherein said triglyceride of saturated C 8 -C 18 fatty acids is dispersed in an amount of 1-3% by weight of the weight of the silicone elastomer.

10. The sheet according to claim 9 , wherein said triglyceride of saturated C 8 -C 18 fatty acids is selected from the group consisting of Caprylic/Capric Triglyceride, Caprylic/Capric/Stearic Triglyceride and Caprylic/Capric/Myristic/Stearic Triglyceride.

11. The sheet according to claim 9 , wherein said triglyceride of saturated C 8 -C 18 fatty acids is Caprylic/Capric Triglyceride.

12. The sheet according to claim 1 , wherein said layer of silicone elastomer has a thickness of between 0.2 and 1.5 mm.

13. The sheet according to claim 1 , wherein said silicone elastomer is a vinyl-substituted polysiloxane crosslinked with a polyalkyl hydrosiloxane.

14. The sheet according to claim 13 , wherein said silicone elastomer is a Bis-Vinyl Dimethicone/Dimethicone Copolymer (INCI nomenclature).

15. A process for the production of a sheet for cutaneous application according to claim 1 comprising a support layer made of loosely woven fabric embedded in a layer of silicone elastomer incorporating vitamin E or an ester thereof, wherein said layer of silicone elastomer has a thickness less than or equal to 2.0 mm, said silicone elastomer contains an elasticity modifier consisting of a triglyceride of saturated C 8 -C 18 fatty acids, and said silicone elastomer is a vinyl-substituted polysiloxane crosslinked with a polyalkyl-hydrosiloxane, which process comprises the steps of:

a) dispersing at room temperature and while stirring the vitamin E or its ester and the triglyceride of saturated C 8 -C 18 fatty acids in a vinyl-substituted polysiloxane, in an amount equal to 3.8-84.4% and 2.9-21.1% by weight of the vinyl-substituted polysiloxane,

b) adding, again while stirring, a polyalkyl hydrosiloxane in a weight ratio with respect to the vinyl-substituted polysiloxane ranging from 0.9:1.0 to 1.1:1.0, obtaining a homogeneous dispersion;

c) depositing on the support layer made of loosely woven fabric said homogeneous dispersion in a layer with a thickness of 0.2-2.0 mm and leaving it at room temperature for a time sufficient to obtain the formation of the sheet.

16. The process according to claim 15 , wherein said vinylsubstituted polysiloxane is Bis-Vinyl Dimethicone and said polyalkylhydrosiloxane is Hydrogen-Dimethicone (INCI nomenclature).

17. The process according to claim 15 , wherein in said step a) vitamin E acetate is dispersed in said vinyl-substituted polysiloxane in an amount of between 7.5-45% by weight of the weight of the vinylsubstituted polysiloxane.

18. The process according to claim 15 , wherein said support layer made of loosely woven fabric is a cotton gauze.

19. A method for treating the formation of keloids and abnormal wound healing processes and for the treatment of already formed keloids in a skin area of a subject, comprising the application of a the sheet according to claim 1 to said skin area.

20. A method for treating sunburn in a skin area of a subject, comprising the application of the sheet according to claim 1 to said skin area.

21. A method for relaxing and moisturizing a skin area of a subject, comprising the application of the sheet according to claim 1 to said skin area.

22. The process according to claim 15 , wherein the weight ratio of polyalkyl hydrosiloxane to vinyl-substituted polysiloxane is 1:1.

23. The process according to claim 15 , where the time sufficient to obtain the formation of the sheet is 2-12 hours.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2022
From: BIO.LO.GA. S.R.L.
To: HULKA S.R.L.
Reel/Frame 059364/0206 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2015
From: INESALUS CORP.
To: BIO.LO.GA S.R.L.
Reel/Frame 034851/0322 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2014
From: PANIN, GIORGIO
To: BIO.LO.GA S.R.L.
Reel/Frame 032263/0859 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2014
From: BIO.LO.GA S.R.L.
To: INESALUS CORP.
Reel/Frame 032263/0865 →
Priority Claims (1)
IT MI2013A0732 · May 6, 2013 · national
Continuity (1)
Related Publication 20140328885A1 · Nov 6, 2014